Altria Group, Inc.
Altria Group Announces Q2 2025 Financial Results and Narrows Full-Year Guidance
Summary
Altria Group, Inc. reported its Q2 2025 financial results on July 30, 2025. The company announced a narrowing of its full-year adjusted diluted earnings per share (EPS) guidance to a range of $5.35 to $5.45, reflecting a growth rate of 3.0% to 5.0% from the 2024 base of $5.19. Net revenues for Q2 2025 were $6.1 billion, a 1.7% decrease from Q2 2024, while adjusted diluted EPS increased by 8.3% to $1.44. For the first half of 2025, net revenues were $11.4 billion, a 3.6% decrease from the first half of 2024, with adjusted diluted EPS rising by 7.2% to $2.67. The company also disclosed share repurchases and dividend payments totaling $3.5 billion in the first half of 2025.
Profitelligence Alerts
Get alerts for MO
Be first to know when Altria Group, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Altria Group, Inc.
Altria Group, Inc. is a holding company with a primary focus on the manufacture and sale of cigarettes and related products. Serving as a leading player in the tobacco industry, Altria is best known for its premium cigarette brand, Marlboro, which holds a significant market share in the United States. Beyond cigarettes, the company has established a diversified portfolio by investing in smokeless tobacco products, wine via its subsidiary Ste. Michelle Wine Estates, and a stake in the cannabis market through its investment in Cronos Group. Altria's strategic expansions into non-cigarette categories reflect its aim to navigate changing consumer preferences and regulatory landscapes. As one of the foremost publicly traded entities in its sector, Altria plays a significant role in the broader consumer goods market. The company continues to engage with shifting market dynamics by fostering innovation in reduced-risk products while maintaining its strong presence in traditional tobacco markets.
Official SEC Documents
Advertisement